Document is current
Any future updates will be listed below
-
Authors
Sullivan, Patricia J.
Gayevskiy, Velimir
Davis, Ryan L.
Wong, Marie
Mayoh, Chelsea
Mallawaarachchi, Amali
Hort, Yvonne
McCabe, Mark J.
Beecroft, Sarah
Jackson, Matilda R.
Arts, Peer
Dubowsky, Andrew
Laing, Nigel
Dinger, Marcel E.
Scott, Hamish S.
Oates, Emily
Pinese, Mark
Cowley, Mark J. http://orcid.org/0000-0002-9519-5714
-
Funding
Funding for this research was provided by:
Cancer Australia (1165556)
Luminesce Alliance
Australian Government Research Training Program (RTP) scholarship
Petre Foundation
Fulbright Association
National Health and Medical Research Council (1176265)
- License Information
-
More Information
Article History
Received: 30 March 2022
Accepted: 10 April 2023
First Online: 17 May 2023
Declarations
:
: Ethics approval for this study was provided by the Hunter New England Human Research Ethics Committee of Hunter New England Local Health District in New South Wales, Australia (Reference No: HC190484).Ethics approval for the use of Human DNA & RNA samples to identify the variants in the SA dataset was provided Central Adelaide Local Health Network Research Ethics in South Australia, Australia (Reference No: R20160813).Ethics approval for the use of Human DNA & RNA samples to identify the variants in the PKD dataset was obtained from the Royal Prince Alfred Hospital Ethics Committee (HREC/18/RPAH/726).
: The authors declare that they have no competing interests.
